Abstract
Telomerase, a RNA-dependent DNA polymerase that adds telomeric DNA at the 3′ ends of eukaryotic chromosomes, is essential for the lifelong preservation of the proliferative potential of antigen specific T lymphocytes. However, senescent T cells that have low telomerase activity, short telomeres and lack of replicative capacity accumulate in old humans, patients with chronic viral infections and cancer. The mechanisms inhibiting telomerase in these cells are poorly understood. Here I describe a strategy that was successfully applied to identify pathways causing telomerase dysfunction in primary human senescent T lymphocytes. Such strategy couples lentiviral vector-based gene manipulations to functional and signaling readouts directly ex vivo, in humans.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blackburn EH (2000) The end of the (DNA) line. Nat Struct Biol 7(10):847–850. doi:10.1038/79594
Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6(8):611–622. doi:10.1038/nrg1656
Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740. doi:10.1038/nrm2233
Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43(2 Pt 1):405–413
Verdun RE, Karlseder J (2007) Replication and protection of telomeres. Nature 447(7147):924–931. doi:10.1038/nature05976
Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621
Hodes RJ, Hathcock KS, Weng NP (2002) Telomeres in T and B cells. Nat Rev Immunol 2(9):699–706. doi:10.1038/nri890
Cong YS, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66(3):407–425
Tesmer VM, Ford LP, Holt SE et al (1999) Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol 19(9):6207–6216
Kyo S, Takakura M, Fujiwara T, Inoue M (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99(8):1528–1538. doi:10.1111/j.1349-7006.2008.00878.x
DePinho RA, Schreiber-Agus N, Alt FW (1991) myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1–46
Akiyama M, Hideshima T, Hayashi T et al (2003) Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63(1):18–21
Crowe DL, Nguyen DC, Tsang KJ, Kyo S (2001) E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res 29(13):2789–2794
Xu D, Wang Q, Gruber A et al (2000) Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19(45):5123–5133. doi:10.1038/sj.onc.1203890
Liu K, Hodes RJ, Weng N (2001) Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 166(8):4826–4830
Kang SS, Kwon T, Kwon DY, Do SI (1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274(19):13085–13090
Henson SM, Franzese O, Macaulay R et al (2009) KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113(26):6619–6628. doi:10.1182/blood-2009-01-199588
Plunkett FJ, Franzese O, Finney HM et al (2007) The loss of telomerase activity in highly differentiated CD8 + CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 178(12):7710–7719
Li H, Zhao LL, Funder JW, Liu JP (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272(27):16729–16732
Di Mitri D, Azevedo RI, Henson SM et al (2011) Reversible senescence in human CD4 + CD45RA + CD27- memory T cells. J Immunol 187(5):2093–2100. doi:10.4049/jimmunol.1100978
Lanna A, Coutavas E, Levati L et al (2013) IFN-alpha inhibits telomerase in human CD8(+) T cells by both hTERT downregulation and induction of p38 MAPK signaling. J Immunol 191(7):3744–3752. doi:10.4049/jimmunol.1301409
Lanna A, Henson SM, Escors D, Akbar AN (2014) The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol 15(10):965–972. doi:10.1038/ni.2981
Escors D, Lopes L, Lin R et al (2008) Targeting dendritic cell signaling to regulate the response to immunization. Blood 111(6):3050–3061. doi:10.1182/blood-2007-11-122408
Acknowledgments
I thank Profs Arne Akbar and Mala Maini for mentorship. I serve as Sir Henry Wellcome Trust Fellow under the sponsorship of Prof. Michael L Dustin (University of Oxford).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lanna, A. (2017). Measuring Telomerase Activity in Senescent Human T Cells Upon Genetic Modification. In: Lugli, E. (eds) T-Cell Differentiation. Methods in Molecular Biology, vol 1514. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6548-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6548-9_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6546-5
Online ISBN: 978-1-4939-6548-9
eBook Packages: Springer Protocols